PSA: New diabetes meds aren't reaching Black patients ⚠️

GLP-1 agonists (Ozempic, Mounjaro):

• 3x more likely prescribed to white patients
• Insurance barriers main issue
• Prior auth requirements discriminatory

We must advocate for our patients. Resources for appeals: [link]

#diabetes #GLP1 #healthdisparities